亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業(yè)會員第1年

武漢遠城科技發(fā)展有限公司銷售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經營的生物化工、醫(yī)藥中間體等產品

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:劉
  • 電話:02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 硫氰酸紅霉素
硫氰酸紅霉素
單價 面議對比
詢價 暫無
發(fā)貨 湖北武漢市付款后3天內
過期 長期有效
更新 2011-04-16 11:43
 
詳細信息
硫氰酸紅霉素 
英文名稱:Erythromycin thiocyanate 
CAS 編號:7704-67-8 
包裝規(guī)格:25kg紙板桶 
規(guī)格型號:99%,醫(yī)藥級 
P H 值 : 6.0-8.0 
灼燒殘渣: ≤ 1.0%
質量標準: 中國藥典BP\USP
外觀性狀: 白色或類白色的結晶性粉末或疏松塊狀物。 
產品含量: 98%
產品用途:抗生素類藥。主要用于革蘭氏陽性菌和之原體的感染,
是國內為生產加工羅紅霉素、琥乙紅霉素、無味紅霉素、克拉紅霉素、

Erythromycin thiocyanate
CAS No. :7704 -67-8
Packing: 25kg cardboard drum
Specification: 99%, pharmaceutical grade
P H value: 6.0-8.0
Residue on ignition: ≤ 1.0%
Quality Standard: Chinese Pharmacopoeia BP \ USP
Appearance: white or almost white crystalline powder or loose
 lumps.
Product content: 98%
Usage: antibiotic medicines. Mainly for Gram-positive bacteria 
and the infection of the original body, is the process for the
 production of roxithromycin, erythromycin ethylsuccinate, 
erythromycin tasteless, Clarithromycin, azithromycin erythromycin
 derivatives series ideal raw material. Also mainly for the 
treatment of penicillin-resistant staphylococcus, streptococcus 
and other infections.
©2025 武漢遠城科技發(fā)展有限公司銷售八部 版權所有   技術支持:化工網   訪問量:27707  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |